Aktie AUROLAB6 AURO LABORATORIES LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Auro Laboratories Limited

Aktien

AUROLAB6

INE292C01011

AUROLAB6

Markt geschlossen - Bombay S.E.
Andere Börsenplätze
 12:12:33 02.05.2024 		% 5 Tage % 1. Jan.
253,4 INR +9,98 % Intraday Chart für Auro Laboratories Limited +24,64 % +95,98 %
30.03. Auro Laboratories Limited gibt das Ausscheiden von Kailash Chand Bubna als unabhängiges Verwaltungsratsmitglied bekannt CI
06.02. Auro Laboratories Limited meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. Dezember 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Auro Laboratories Limited Announces Cessation of Kailash Chand Bubna as Independent Director
Auro Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Auro Laboratories Limited Appoints Shaan Jain as Chief Financial Officer
Auro Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Auro Laboratories Limited Announces the Resignation of Amit Mahipat Shah as Chief Financial Officer, Effective October 1, 2023
Auro Laboratories Limited Appoints Vishal Kailashchandra Jhunjhunwala as an Non-Executive & Independent Director
Auro Laboratories Plans to Spend INR400 Million to Expand Capacity of Metformin HCL Factory
Auro Laboratories Limited Announces Intimation Regarding Capacity Expansion
Auro Laboratories Limited Announces Resignation of Govardhan Das Agarwal as Director
Auro Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Auro Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Auro Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Auro Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Auro Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Auro Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022
Auro Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2022
Auro Laboratories Limited Announces Management Changes
Auro Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
Auro Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
Auro Laboratories Limited Approves the Appointment of Kiran Kulkarni as the Whole-Time Director of the company
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. AUROLAB6 Aktie
  4. Nachrichten Auro Laboratories Limited
  5. Andere Sprachen